Valuation : Cipla Limited

Market Cap 1,11900Cr 1.19TCr 1.02TCr 959.43Cr 876.44Cr 1.64TCr 1.64TCr 11TCr 4.4TCr 57TCr 4.45TCr 4.35TCr 1,84900Cr P/E 2027 *
27x
P/E 2028 * 21.7x
Enterprise Value 1,01300Cr 1.07TCr 923.06Cr 868.47Cr 793.35Cr 1.48TCr 1.49TCr 10TCr 3.98TCr 52TCr 4.03TCr 3.94TCr 1,67400Cr EV / Sales 2027 *
3.27x
EV / Sales 2028 * 2.84x
Free-Float
68.87%
Yield 2027 *
0.94%
Yield 2028 * 1.06%
1 day-0.70%
1 week-2.70%
Current month-1.72%
1 month-5.06%
3 months-1.16%
6 months+4.42%
Current year-8.36%
1 week 1,375.5
Extreme 1375.5
1,426.1
1 month 1,375.5
Extreme 1375.5
1,483.7
Current year 1,165.7
Extreme 1165.7
1,539.7
1 year 1,165.7
Extreme 1165.7
1,673
3 years 1,132
Extreme 1132
1,702.05
5 years 850
Extreme 850
1,702.05
10 years 355.3
Extreme 355.3
1,702.05
Manager TitleAgeSince
Chief Executive Officer - 01/04/2026
President - 18/05/2026
Director of Finance/CFO - 24/07/2026
Director TitleAgeSince
Chairman 90 21/07/1972
Director/Board Member 72 25/07/2014
Director/Board Member 71 30/06/2021
Date Insider Type Main position Quantity % Market Cap. Importance
22/08/24 Sell 2,000 0.0002%
14/08/24 Sell 3,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.70%-2.70%-10.84%+11.79% 1.19TCr
-0.89%-1.09%+19.16%+67.77% 4.83TCr
-1.72%-1.15%+45.80%+117.34% 4.05TCr
-2.01%-5.96%+10.47%+76.64% 1.18TCr
+2.31%0.00%+26.67%+153.33% 935.93Cr
+0.08%-4.11%+24.83%+43.80% 749.58Cr
-1.67%-0.35%+41.04%-11.59% 737.27Cr
-0.89%-3.09%+18.78%+207.82% 728.46Cr
-0.16%-2.36%-46.14%+16.28% 518.68Cr
-1.60%-2.59%+32.54%+102.62% 458.48Cr
Average -0.72%-2.14%+16.23%+78.58% 1.54TCr
Weighted average by Cap. -0.97%-1.74%+23.16%+83.37%

Financials

2027 *2028 *
Net sales 31TCr 328.21Cr 282.43Cr 265.72Cr 242.74Cr 454.09Cr 455.33Cr 3.14TCr 1.22TCr 16TCr 1.23TCr 1.21TCr 51TCr 35TCr 367.84Cr 316.53Cr 297.81Cr 272.05Cr 508.92Cr 510.31Cr 3.52TCr 1.37TCr 18TCr 1.38TCr 1.35TCr 57TCr
Net income 4.14TCr 44Cr 38Cr 35Cr 32Cr 61Cr 61Cr 419.04Cr 162.61Cr 2.12TCr 164.48Cr 160.89Cr 6.84TCr 5.14TCr 54Cr 47Cr 44Cr 40Cr 75Cr 76Cr 520.98Cr 202.16Cr 2.64TCr 204.49Cr 200.03Cr 8.5TCr
Net Debt -11TCr -112.35Cr -97Cr -91Cr -83Cr -155.44Cr -155.86Cr -1.07TCr -417.08Cr -5.44TCr -421.87Cr -412.67Cr -18TCr -13TCr -139.22Cr -119.8Cr -112.71Cr -102.96Cr -192.61Cr -193.14Cr -1.33TCr -516.83Cr -6.74TCr -522.78Cr -511.38Cr -22TCr
Logo Cipla Limited
Cipla specializes in development, manufacturing and marketing of pharmaceutical products. The group provides prescription products and OTC medicines for the treatment of cardiovascular, ophthalmic and dermatological diseases, respiratory troubles, cancers, allergies, infections etc. Besides, Cipla develops and sells veterinary products. Net sales by source of income break down between sale of products (96.9%) and services (3.1%). Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).
Employees
31,369
Date Price Change Volume
04/26/04 ₹1,385.00 -0.70% 13,26,180
03/26/03 ₹1,394.70 -1.28% 5,49,749
02/26/02 ₹1,412.80 -0.72% 5,78,260
01/26/01 ₹1,423.00 +0.98% 8,80,100
31/26/31 ₹1,409.20 -1.00% 9,77,929
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
1,385.00INR
Average target price
1,509.08INR
Spread / Average Target
+8.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CIPLA Stock